MX2020013000A - Composicion de hidrogel que comprende polimero reticulado. - Google Patents

Composicion de hidrogel que comprende polimero reticulado.

Info

Publication number
MX2020013000A
MX2020013000A MX2020013000A MX2020013000A MX2020013000A MX 2020013000 A MX2020013000 A MX 2020013000A MX 2020013000 A MX2020013000 A MX 2020013000A MX 2020013000 A MX2020013000 A MX 2020013000A MX 2020013000 A MX2020013000 A MX 2020013000A
Authority
MX
Mexico
Prior art keywords
thiol
crosslinked polymer
hyaluronan
hydrogel composition
modification
Prior art date
Application number
MX2020013000A
Other languages
English (en)
Inventor
Martin Prinz
Ralph Hollaus
Robert Sachsenhofer
Original Assignee
Croma Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Croma Pharma Gmbh filed Critical Croma Pharma Gmbh
Publication of MX2020013000A publication Critical patent/MX2020013000A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction

Abstract

Una composición de hidrogel estéril que comprende un polímero reticulado, en donde el polímero reticulado es un producto de oxidación de un hialuronano modificado con tiol y en donde el hialuronano modificado con tiol tiene un grado de modificación de hialuronano con restos de tiol de más de aproximadamente 80 µmol por gramo de polímero, en donde el hialuronano modificado con tiol tiene un grado de modificación de hialuronano con restos de tiol de menos de aproximadamente 280 µmol por gramo de polímero, en donde la composición tiene un contenido de tiol residual de menos de 20% con respecto al grado de modificación del hialuronano modificado con tiol.
MX2020013000A 2018-06-15 2019-06-14 Composicion de hidrogel que comprende polimero reticulado. MX2020013000A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP18178099 2018-06-15
EP18178098 2018-06-15
EP18178097 2018-06-15
PCT/EP2019/065755 WO2019238954A1 (en) 2018-06-15 2019-06-14 Hydrogel composition comprising a crosslinked polymer

Publications (1)

Publication Number Publication Date
MX2020013000A true MX2020013000A (es) 2021-03-29

Family

ID=66821271

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020013000A MX2020013000A (es) 2018-06-15 2019-06-14 Composicion de hidrogel que comprende polimero reticulado.

Country Status (11)

Country Link
US (2) US20210259943A1 (es)
EP (2) EP3806918A1 (es)
JP (2) JP7374133B2 (es)
KR (2) KR20210021363A (es)
CN (3) CN112334167A (es)
BR (2) BR112020024637B1 (es)
CA (2) CA3101412A1 (es)
IL (2) IL279446A (es)
MA (2) MA52880A (es)
MX (1) MX2020013000A (es)
WO (2) WO2019238954A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220403054A1 (en) * 2019-12-19 2022-12-22 Croma-Pharma Gmbh Thiol-modified hyaluronan and hydrogel comprising the crosslinked hyaluronan
CN115702937A (zh) * 2021-08-04 2023-02-17 四川大学 改性多酚载体材料、靶向纳米递送系统及制备方法和用途
KR20230145624A (ko) * 2022-04-08 2023-10-18 (주)아크로스 안전성이 우수한 조직수복용 생체재료의 제조 방법
CN115414276A (zh) * 2022-06-24 2022-12-02 辽宁德玛生物科技有限公司 一种注射用琼脂糖凝胶剂及其制备方法
EP4335876A1 (en) * 2022-09-06 2024-03-13 Scivision Biotech Inc. Method of manufacturing auto-crosslinked hyaluronic acid gel and products thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582865A (en) * 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US6174999B1 (en) 1987-09-18 2001-01-16 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
US6630457B1 (en) 1998-09-18 2003-10-07 Orthogene Llc Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same
DE60207831D1 (de) 2001-02-22 2006-01-12 Anika Therapeutics Inc Thiol-modifizierte hyaluronan-derivate
CA2489712C (en) 2002-06-21 2016-07-12 University Of Utah Research Foundation Crosslinked compounds and methods of making and using thereof
JP4993465B2 (ja) 2003-12-04 2012-08-08 ユニバーシティ オブ ユタ リサーチ ファウンデーション 変性された高分子ならびにその製造方法および使用方法
US8143391B2 (en) 2004-09-07 2012-03-27 Chugai Seiyaku Kabushiki Kaisha Process for producing water-soluble hyaluronic acid modification
EP2038308A2 (en) 2006-07-11 2009-03-25 University of Utah Research Foundation Thiolated macromolecules and methods of making and using thereof
FR2909560B1 (fr) * 2006-12-06 2012-12-28 Fabre Pierre Dermo Cosmetique Gel d'acide hyaluronique pour injection intradermique
CN101200504B (zh) 2006-12-11 2010-05-12 上海百瑞吉生物医药有限公司 高分子巯基化改性衍生物及其交联材料
DK2107913T3 (da) 2006-12-22 2012-05-21 Croma Pharma Ges M B H Anvendelse af thiolerede polysaccharider til vævsopbygning
WO2009005790A2 (en) * 2007-06-29 2009-01-08 Carbylan Biosurgery, Inc. Sterile thiol-derivatized hyaluronic acid polymer compositions and uses thereof
CA2694089A1 (en) * 2007-07-16 2009-01-22 Northeastern University Therapeutic stable nanoparticles
US9161970B2 (en) * 2007-12-12 2015-10-20 Allergan, Inc. Dermal filler
CN101367884A (zh) 2008-09-25 2009-02-18 复旦大学 一种半胱胺修饰的巯基化透明质酸偶合物及其制备方法和应用
CN101721349B (zh) * 2008-10-16 2011-07-20 常州百瑞吉生物医药有限公司 可注射原位交联水凝胶及其制备方法和用途
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
CN102399295B (zh) * 2010-09-09 2013-11-06 常州百瑞吉生物医药有限公司 低巯基化改性度生物相容高分子巯基化衍生物及其交联材料和用途
US9149422B2 (en) * 2011-06-03 2015-10-06 Allergan, Inc. Dermal filler compositions including antioxidants
US9393263B2 (en) * 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
KR20200116168A (ko) * 2011-09-14 2020-10-08 알러간, 인코포레이티드 잔주름 치료를 위한 진피 필러 조성물
HUE050947T2 (hu) 2011-12-08 2021-01-28 Allergan Ind Sas Dermális töltõkészítmények
FR2997014B1 (fr) 2012-10-24 2015-03-20 Teoxane Composition sterile dermo-injectable
US20160082150A1 (en) 2013-05-08 2016-03-24 Allergan Industrie S.A.S. Hyaluronic acid gels crosslinked by sodium trimetaphosphate
ITMI20131193A1 (it) * 2013-07-16 2015-01-17 Ira Srl Acido ialuronico reticolato, processo per la sua preparazione ed applicazioni in ambito estetico
WO2016005785A1 (en) 2014-07-11 2016-01-14 Allergan Industrie, Sas Hyaluronic acid gels crosslinked by sodium trimetaphosphate
CN104892962B (zh) * 2015-06-05 2017-12-08 四川大学 一种巯基/二硫键可控自交联透明质酸水凝胶的制备方法及其应用
IT201600096125A1 (it) * 2016-09-26 2018-03-26 Ntc Srl Complesso e composizioni per il trattamento di affezioni oculari e cutanee

Also Published As

Publication number Publication date
WO2019238955A1 (en) 2019-12-19
BR112020024637B1 (pt) 2024-01-30
JP7374133B2 (ja) 2023-11-06
JP2021526934A (ja) 2021-10-11
IL279445A (en) 2021-01-31
US20210260243A1 (en) 2021-08-26
CA3101410A1 (en) 2019-12-19
CN112334167A (zh) 2021-02-05
CN112334165A (zh) 2021-02-05
CA3101412A1 (en) 2019-12-19
KR20210021363A (ko) 2021-02-25
BR112020024637A2 (pt) 2021-03-02
MA52880A (fr) 2021-09-22
WO2019238954A1 (en) 2019-12-19
BR112020024735A2 (pt) 2021-03-23
EP3806919A1 (en) 2021-04-21
US20210259943A1 (en) 2021-08-26
MA52877A (fr) 2021-04-21
CN116650519A (zh) 2023-08-29
EP3806918A1 (en) 2021-04-21
JP2021526933A (ja) 2021-10-11
IL279446A (en) 2021-01-31
BR112020024735B1 (pt) 2024-02-27
KR20210021362A (ko) 2021-02-25

Similar Documents

Publication Publication Date Title
MX2020013000A (es) Composicion de hidrogel que comprende polimero reticulado.
MX2016013710A (es) Solucion oftalmica acuosa y metodo para tratar el sindrome del ojo seco.
MX2013008665A (es) Sistemas de suministro de fármaco.
MY159678A (en) Bimodal neodymium-catalyzed polybutadiene
WO2014055532A3 (en) Dermal filler hydrogels with vitamin a/cyclodextrin inclusion complexes
MX2010008257A (es) Cauchos de nitrilo que contienen opcionalmente grupos terminales alquiltio que estan opcionalmente hidrogenados.
AU2018236629A8 (en) Hydrogel patch
MY176435A (en) Ndbr with molar mass breakdown
MX2017000346A (es) Resina absorbente al agua y articulo absorbente.
MX2020013006A (es) Composicion de hidrogel que comprende polimero reticulado.
MX2011007495A (es) Conversion incrementada de monomero en polimerizacion en emulsion.
WO2021146320A8 (en) Antibody molecules to c5ar1 and uses thereof
MX2021000583A (es) Producto de grafeno y usos terapeuticos del mismo.
EP4273239A3 (en) Polymeric particles containing microorganisms
AU2017394032A8 (en) Use of paeoniflorin-6'-o-benzenesulfonate in treatment of sjögren's syndrome
PH12019501606A1 (en) Methods of treating bacterial infections
MX370164B (es) Composicion cosmetica destinada a maquillar la piel, producto cosmetico y uso cosmetico de polisacaridos de babasu.
MX2022008063A (es) Hidrogeles de acido hialuronico (ha)-colageno reticulados como rellenos dermicos.
WO2019236043A3 (en) Uv-curable, biocompatible, superamphiphobic coating
WO2018065391A3 (en) Hyaluronan compositions, and uses thereof in treatment of interstitial cystitis
MX2022003814A (es) Compuestos antibacterianos de 4-quinolinona.
MX2022003384A (es) Polimeros que contienen acido fenil boronico sustituido y metodos de uso.
RS54013B1 (en) HIGH-ELASTIC GELS IN OPTAMOLOGICAL SURGERY
MD20210039A2 (ro) Material polimeric cu proprietăţi antimicrobiene
MX2017017192A (es) Biopolimero de quitosano y poloxamero 407 obtenido por irradiacion gamma que exhibe propiedades fisicoqumicas y biologicas para la reparacion de heridas.